Cheyne Kurokawa is the Senior Director of Virology at IntegerBio, where they lead vaccine development efforts. Previously, Cheyne served as a Senior Scientist and Associate Director at AstraZeneca, and as a Postdoctoral Researcher at Yale University, focusing on gene signatures related to anti-tick vaccination. Cheyne earned a PhD in Virology and Gene Therapy from the Mayo Clinic Graduate School of Biomedical Sciences, where they developed innovative biomarker assays for glioblastoma therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices